Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Antiphospholipid Syndrome

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Antiphospholipid Syndrome:

Pubmed Logo
[Cerebral venous thrombosis: when etiology makes the difference.]
Objectives. To make a retrospective study of the clinical, etiological,...
19th November, 2009
Neurologia. 2009 Sep;24(7):439-445.
Role of Tissue Factor in the Maternal Immunological Attack of the Embryo in the Antiphospholipid Syndrome.
Recurrent fetal loss affects 1-5% of women of childbearing age....
19th November, 2009
Department of Medicine, Weill Medical College of Cornell University, New Clin Rev Allergy Immunol. 2009 Nov 17.
DOI Direct Link
Pharmacokinetics of LJP 993, a tetrameric conjugate of domain 1 of B2-glycoprotein I for antiphospholipid syndrome.
beta2-glycoprotein I is the best-characterized antigenic target for...
19th November, 2009
La Jolla Pharmaceutical Company, San Diego CA, USA. Lupus. 2009 Nov 17.
DOI Direct Link
Management of antiphospholipid syndrome.
beta2-glycoprotein I is the best-characterized antigenic target for...
17th November, 2009
Rinsho Ketsueki. 2009 Oct;50(10):1427-33.
Secondary adrenal insufficiency and primary antiphospholipid syndrome.
A woman with isolated ACTH deficiency and empty sella in a background of...
17th November, 2009
Department of Medicine, Endocrine Section, Taibah University, Madinah Intern Med. 2009;48(22):1963-6. Epub 2009 Nov 16.

View more research publications.

Press Releases About Antiphospholipid Syndrome:

BioPortfolio Logo
U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 25th November, 2009 Tibotec Therapeutics
- Severe, potentially life-threatening, and fatal skin reactions have been reported in patients taking INTELENCE. These include cases of Stevens-Johnson syndrome, toxic
Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 25th November, 2009 Regado Biosciences
BASKING RIDGE, N.J., Nov. 25 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David Mazzo, PhD
Reportlinker Adds Probiotics - A Global Update of Market Trends & Opportunities 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Probiotics - A Global Update of Market Trends & Opportunities http:/
DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 24th November, 2009 DynaVox Mayer-Johnson
PITTSBURGH, Nov. 24 /PRNewswire/ -- WHAT: Rom Houbens, a Belgian man thought to have been in coma for 23 years following an auto accident, was actually fully conscious and awake during that time and
Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 23rd November, 2009 Lexicon Pharmaceuticals, Inc.
THE WOODLANDS, Texas, Nov. 23 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that top-line data from its Phase 2 clinical study with LX1031 in patients with

BioNews Results for Antiphospholipid Syndrome:

RSS Logo
BioPortfolio Logo
Thrombin Activatable Fibrinolysis Inhibitor and Clot Lysis Time in Pregnant Patients with Antiphospholipid Syndrome: Relationship with Pregnancy Outcome and Thrombosis
MDLinx:  Nov 13 2009 11:04AM Matching: antiphospholipid syndrome

Antiphospholipid Syndrome Clinical Trials:

Clinical Trials Logo
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Antiphospholipid Syndrome Patents:

USPTO Logo
US Patent No.Title
7498313 Large circular target-specific antisense nucleic acid compounds
7534605 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
7541434 Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants
7541441 Antibodies that specifically bind to TL5
7547687 Therapeutic treatment methods

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Antiphospholipid Syndrome scientists - we have details of around 532 individuals working on Antiphospholipid Syndrome .


This page has been viewed 413 times
Recent Search Terms used to find this page: New approaches for managing antiphospholipid syndrome | q antiphospholipid syndrome | antiphospholipid syndrome | antiphospholipid syndrome 2009 | Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background | Nat Clin Pract Rheumatol New approaches for managing antiphospholipid syndrome | antiphospholipid syndrome | antiphospholipid 2009 | antiphospholipid syndrome 2009 | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Antiphospholipid Syndrome across BioPortfolio, or for Antiphospholipid Syndrome Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.